Leading a Young Company with a Five-Generation History with Jean-Frédéric Chibret - a podcast by OIS Podcast

France-based Théa Laboratories may be only 27 years old, but its legacy goes back 150 years. It reaches back to the 1870s, when ophthalmologist Paul Chibret became fascinated with trachoma. He would later help found the French Society of Ophthalmology. Five generations of Chibret doctors and entrepreneurs later, the Chibret family’s passion for eye care has led to the development of one of Europe’s leading eye-care companies. 

Now led by chairman Jean-Frédéric Chibret, MBA, the company remains independent, family owned, and 100% ophthalmology focused. While honoring those company values, Jean-Frédéric stays focused on growth. Revenue has increased from €150 million in 2008 to €600 million in 2020. The majority of that—75%—has taken place outside France. 

Théa’s next goal: commercialization in the United States.

Listen to Jean-Frédéric’s “fireside chat” with Emmetrope founder Joseph Sullivan to discover:

? Théa’s objectives for the next few years in both existing and new markets.

? The progress Théa Open Innovation has made implementing licensing agreements and capital investments with early stage partners. The subsidiary has already signed agreements that help advance treatments for myopia, wet and dry age-related macular degeneration and macular edema.

?  How Théa became a leader in Europe and how it plans to continue to use its business formula to tap into the U.S. market.

Further episodes of OIS Podcast | Ophthalmology

Further podcasts by OIS Podcast

Website of OIS Podcast